A detailed history of China Universal Asset Management Co., Ltd. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 27,896 shares of ADPT stock, worth $98,751. This represents 0.01% of its overall portfolio holdings.

Number of Shares
27,896
Previous 27,896 -0.0%
Holding current value
$98,751
Previous $90,000 1.11%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$2.88 - $4.8 $32,109 - $53,515
11,149 Added 66.57%
27,896 $90,000
Q4 2023

May 21, 2024

SELL
$3.46 - $5.33 $38,575 - $59,424
-11,149 Reduced 39.97%
16,747 $82,000
Q4 2023

Jan 23, 2024

BUY
$3.46 - $5.33 $45,076 - $69,439
13,028 Added 350.31%
16,747 $82,000
Q3 2023

May 21, 2024

BUY
$5.07 - $8.44 $9,267 - $15,428
1,828 Added 96.67%
3,719 $20,000
Q3 2023

Oct 30, 2023

BUY
$5.07 - $8.44 $9,267 - $15,428
1,828 Added 96.67%
3,719 $20,000
Q2 2023

May 21, 2024

SELL
$6.19 - $8.78 $303 - $430
-49 Reduced 2.53%
1,891 $12,000
Q2 2023

Jul 27, 2023

SELL
$6.19 - $8.78 $303 - $430
-49 Reduced 2.53%
1,891 $13,000
Q1 2023

May 21, 2024

BUY
$7.8 - $10.11 $3,798 - $4,923
487 Added 33.52%
1,940 $17,000
Q1 2023

Apr 27, 2023

BUY
$7.8 - $10.11 $3,798 - $4,923
487 Added 33.52%
1,940 $17,000
Q4 2022

May 21, 2024

SELL
$6.26 - $9.34 $165,533 - $246,977
-26,443 Reduced 94.79%
1,453 $11,000
Q4 2022

Jan 31, 2023

BUY
$6.26 - $9.34 $719 - $1,074
115 Added 8.59%
1,453 $11,000
Q3 2022

Oct 21, 2022

BUY
$6.5 - $12.67 $8,697 - $16,952
1,338 New
1,338 $10,000

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $506M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.